 |
 |
 |
 |
 |
|
|
Contact | Print version | PDF version | Recommend company
|
Grillparzerstraße 10 81765 München
Germany
|
|
Portrait Wilex, founded 1997, is developing novel cancer therapies for the treatment of solid tumors including renal cell cancer, breast, and colon cancer. Therapies are tailored to the individual needs of cancer patients to provide effective and well-tolerated treatment. Wilex has 2 therapeutic platforms: monoclonal antibodies and anti-metastatic small molecules. Wilex has 3 products in clinical trials.
Industrial Sectors
Additional information
Wilex AG München, Germany
News
|
|
|
|
|
|